Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -97,073 | 94,284 | 79,847 | 80,985 | 63,859 |
| Depreciation Amortization | 20,867 | 22,605 | 23,087 | 24,524 | 26,872 |
| Income taxes - deferred | -12,216 | -36,345 | 1,832 | 9,015 | -14,385 |
| Accounts receivable | 46,421 | -3,191 | 2,265 | -18,565 | 31,584 |
| Accounts payable and accrued liabilities | -12,838 | -3,757 | -1,752 | 8,721 | -1,036 |
| Other Working Capital | 5,939 | -7,707 | -28,991 | -8,485 | 35,202 |
| Other Operating Activity | 106,768 | 23,638 | 35,539 | 28,076 | -10,209 |
| Operating Cash Flow | $57,868 | $89,527 | $111,827 | $124,271 | $131,887 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10,146 | -21,382 | -20,859 | -18,073 | -10,616 |
| Net Acquisitions | -225 | 2,980 | -47,314 | N/A | -1,242 |
| Purchase Sale Intangibles | -498 | -180 | -1,190 | -379 | -348 |
| Other Investing Activity | 18,222 | 12,725 | -2,466 | -2,484 | -2,863 |
| Investing Cash Flow | $7,851 | $-5,677 | $-70,639 | $-20,557 | $-14,721 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 56,000 | 138,000 | 178,000 | 140,000 | 99,000 |
| Debt Repayment | -102,000 | -123,000 | -114,000 | -130,000 | -316,244 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 197,202 |
| Common Stock Repurchased | -2,793 | -3,308 | -7,451 | -16,909 | -7,161 |
| Dividend Paid | -12,446 | -97,574 | -97,251 | -97,143 | -96,531 |
| Other Financing Activity | -1,766 | 8 | -1,770 | -26 | -1,162 |
| Financing Cash Flow | $-63,005 | $-85,874 | $-42,472 | $-104,078 | $-124,896 |
| Beginning Cash Position | 11,092 | 13,116 | 14,400 | 14,764 | 22,494 |
| End Cash Position | 13,806 | 11,092 | 13,116 | 14,400 | 14,764 |
| Net Cash Flow | $2,714 | $-2,024 | $-1,284 | $-364 | $-7,730 |
| Free Cash Flow | |||||
| Operating Cash Flow | 57,868 | 89,527 | 111,827 | 124,271 | 131,887 |
| Capital Expenditure | -11,880 | -22,269 | -21,741 | -18,775 | -11,356 |
| Free Cash Flow | 45,988 | 67,258 | 90,086 | 105,496 | 120,531 |